Autopsy report · NCT00769093

Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving Chemotherapy

“Inadequate enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 9 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

OHSU Knight Cancer Institute

Sponsor type

University, hospital or other

Conditions

Brain Neoplasms

Interventions

Ferumoxytol

Participants

6

Sites

1

Countries

United States

Trials that died the same way

• Prophylactic Phenobarbital After Neonatal Seizures
  “Inadequate rate of enrollment” (92% match in meaning)
• Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)
  “Lack of enrollment” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.